rs794728708
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001035.3(RYR2):c.527G>A(p.Arg176Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R176L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001035.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.527G>A | p.Arg176Gln | missense_variant | Exon 8 of 105 | 1 | NM_001035.3 | ENSP00000355533.2 | ||
RYR2 | ENST00000609119.2 | n.527G>A | non_coding_transcript_exon_variant | Exon 8 of 104 | 5 | ENSP00000499659.2 | ||||
RYR2 | ENST00000660292.2 | c.527G>A | p.Arg176Gln | missense_variant | Exon 8 of 106 | ENSP00000499787.2 | ||||
RYR2 | ENST00000659194.3 | c.527G>A | p.Arg176Gln | missense_variant | Exon 8 of 105 | ENSP00000499653.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia 1 Pathogenic:3
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 176 of the RYR2 protein (p.Arg176Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with catecholaminergic polymorphic ventricular tachycardia (PMID: 11159936, 16188589, 18752142, 20106799; internal data). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 201194). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RYR2 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RYR2 function (PMID: 16873551, 20157052, 27482086). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
not provided Pathogenic:2
Reported in association with LQTS and CPVT, also described as "ARVD2" in some publications (Tiso et al., 2001; Bauce et al., 2002; Tester et al., 2005; Berge et al., 2008; Haugaa et al., 2010); Reported in ClinVar as a pathogenic variant (ClinVar Variant ID# 201194; Landrum et al., 2016); Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate a damaging effect as mice that are heterozygous for this variant developed frequent PVCs with isoproterenol while the wild-type mice did not and concluded that R176Q is sufficient to cause catecholamine-induced VT (Kannankeril et al., 2006; Mathur et al., 2009); Additional published functional studies demonstrate a damaging effect in HEK293 cells as this variant results an increase in peak calcium release (Thomas et al., 2004; Jiang et al., 2005; Tang et al., 2012); Located in one of the three hot-spot regions of the RYR2 gene, where the majority of pathogenic missense variants occur (Medeiros-Domingo et al., 2009); This variant is associated with the following publications: (PMID: 19603549, 24136861, 22158709, 23978697, 23152493, 11159936, 31112425, 19226252, 24025405, 16239587, 15364613, 25372681, 16873551, 16188589, 20106799, 22374134, 20009080, 12106942, 18752142, 19926015, 25901278) -
- -
RYR2-related disorder Pathogenic:1
PS2, PS3, PS4, PM1, PM2, PP3 -
Arrhythmogenic right ventricular dysplasia 2 Pathogenic:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
Cardiovascular phenotype Pathogenic:1
The p.R176Q pathogenic mutation (also known as c.527G>A), located in coding exon 8 of the RYR2 gene, results from a G to A substitution at nucleotide position 527. The arginine at codon 176 is replaced by glutamine, an amino acid with highly similar properties. This alteration has been reported in association with arrhythmia phenotypes, including detection in individuals with syncope with and without reported QTc prolongation, and catecholaminergic polymorphic ventricular tachycardia (CPVT) (Tester DJ et al. Heart Rhythm, 2005 Oct;2:1099-105; Medeiros-Domingo A et al. J. Am. Coll. Cardiol., 2009 Nov;54:2065-74; Berge KE et al. Scand. J. Clin. Lab. Invest., 2008;68:362-8; Haugaa KH et al. Europace, 2010 Mar;12:417-23). This alteration has also been reported to co-occur with a second RYR2 variant in a family with arrhythmogenic right ventricular cardiomyopathy (Tiso N et al. Hum. Mol. Genet., 2001 Feb;10:189-94). In addition, inducible ventricular arrhythmias including bi-directional and polymorphic ventricular tachycardia have been demonstrated in mouse models expressing p.R176Q (Kannankeril PJ et al. Proc. Natl. Acad. Sci. U.S.A., 2006 Aug;103:12179-84; Li N. Int. J. Cardiol. 2017 Jan;227:668-673). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at